Table 2. Unadjusted associations between measures of endothelial glycocalyx dimension and cardio-renal risk factors in the persons with type 1 diabetes (n = 136).
PBR | PBR-hf | MicroVascular Health Score | ||||
---|---|---|---|---|---|---|
β | P | β | P | β | P | |
Age | 0.04 | 0.17 | 0.01 | 0.70 | -0.10 | 0.39 |
Female sex | 0.08 | 0.14 | 0.12 | 0.01 | -0.60 | 0.01 |
Diabetes duration | -0.01 | 0.57 | -0.005 | 0.84 | 0.10 | 0.42 |
Body mass index | -0.04 | 0.17 | -0.02 | 0.49 | 0.13 | 0.23 |
24h systolic BP | 0.003 | 0.93 | 0.01 | 0.82 | 0.16 | 0.19 |
HbA1c | -0.01 | 0.62 | 0.003 | 0.91 | 0.07 | 0.53 |
LDL cholesterol | -0.01 | 0.79 | -0.01 | 0.61 | 0.11 | 0.32 |
eGFR | -0.02 | 0.34 | -0.01 | 0.71 | -0.002 | 0.99 |
UACR | 0.02 | 0.49 | -0.03 | 0.18 | 0.19 | 0.11 |
Current smoking | -0.03 | 0.69 | 0.004 | 0.96 | -0.22 | 0.52 |
Retinopathy | -0.01 | 0.66 | -0.002 | 0.95 | 0.21 | 0.17 |
History of cardiovascular disease | 0.02 | 0.69 | -0.01 | 0.81 | -0.16 | 0.54 |
The β-estimates represent standardized effect. PBR: Perfused Boundary Region; PBR-hf: Perfused Boundary Region at a fixed high flow level; UACR: urine albumin creatinine ratio.